Akero Therapeutics Inc (AKRO)

Akero Therapeutics (AKRO) Stock Price & Analysis


AKRO Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$7.52 - $54.88
Previous Close$38.32
Average Volume (3M)597.22K
Market Cap
Enterprise Value$1.83B
Total Cash (Recent Filing)€0.00
Total Debt (Recent Filing)€0.00
Price to Earnings (P/E)-13.1
May 17, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.93
Shares Outstanding46,970,989
10 Day Avg. Volume826,625
30 Day Avg. Volume597,216
Standard Deviation0.32
Financial Highlights & Ratios
Price to Book (P/B)5.39
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-19.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside54.61% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Akero Therapeutics Inc’s price range in the past 12 months?
Akero Therapeutics Inc lowest stock price was $7.52 and its highest was $54.88 in the past 12 months.
    What is Akero Therapeutics Inc’s market cap?
    Currently, no data Available
    When is Akero Therapeutics Inc’s upcoming earnings report date?
    Akero Therapeutics Inc’s upcoming earnings report date is May 17, 2023 which is in 49 days.
      How were Akero Therapeutics Inc’s earnings last quarter?
      Akero Therapeutics Inc released its earnings results on Mar 17, 2023. The company reported -$0.49 earnings per share for the quarter, beating the consensus estimate of -$0.783 by $0.293.
        Is Akero Therapeutics Inc overvalued?
        According to Wall Street analysts Akero Therapeutics Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Akero Therapeutics Inc pay dividends?
          Akero Therapeutics Inc does not currently pay dividends.
          What is Akero Therapeutics Inc’s EPS estimate?
          Akero Therapeutics Inc’s EPS estimate is -$0.7.
            How many shares outstanding does Akero Therapeutics Inc have?
            Akero Therapeutics Inc has 46,970,990 shares outstanding.
              What happened to Akero Therapeutics Inc’s price movement after its last earnings report?
              Akero Therapeutics Inc reported an EPS of -$0.49 in its last earnings report, beating expectations of -$0.783. Following the earnings report the stock price went up 1.233%.
                Which hedge fund is a major shareholder of Akero Therapeutics Inc?
                Among the largest hedge funds holding Akero Therapeutics Inc’s share is Baker Bros Advisors LP. It holds Akero Therapeutics Inc’s shares valued at 130M.


                  Akero Therapeutics Stock Smart Score

                  The Akero Therapeutics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Akero Therapeutics Inc

                  Akero Therapeutics, Inc. operates as a biotechnology company. The firm specializes in transformational treatments for non-alcoholic steatohepatitis (NASH) and other serious metabolic diseases. The company was founded by Jonathan Young and Timothy Rolph on January 24, 2017 and is headquartered in South San Francisco, CA.


                  Top 5 ETFs holding AKRO

                  Market Value
                  Smart Score
                  Simplify Propel Opportunities ETF
                  Fidelity Nasdaq Composite Index ETF
                  Vanguard ESG U.S. Stock ETF
                  Dimensional US Core Equity Market ETF
                  Up to five ETFs with an Outperform Smart Score that hold AKRO. The ETFs are listed according to market value of AKRO within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  ACADIA Pharmaceuticals
                  SAGE Therapeutics
                  Arcus Biosciences
                  Relay Therapeutics

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis